New scan could give early clues for rare lung disease treatment
NCT ID NCT05467397
Summary
This study is testing whether a special type of PET scan can show early signs that a drug called rapamycin is working in patients with a rare lung disease called LAM. Researchers want to see if the scan can detect changes in tumor metabolism before other tests show improvement. A small group of adult women with LAM will receive 1-2 of these scans over several months to gather initial data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBEROUS SCLEROSIS COMPLEX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.